SMTL ID : 4cfn.1 (1 other biounit)

Structure-based design of C8-substituted O6-cyclohexylmethoxyguanine CDK1 and 2 inhibitors.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

hetero-1-1-mer

Ligands

1 x JYM: 6-(cyclohexylmethoxy)-8-(trifluoromethyl)-9H-purin-2-amine(Non-covalent)

JYM.1: 14 residues within 4Å: Chain A: I.14, G.15, E.16, G.17, V.22, A.35, V.68, F.84, L.87, H.88, Q.89, D.90, Q.135, L.138 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:Q.135 Hydrogen bonds: A:H.88 Water bridges: A:L.87, A:L.87, A:D.90, A:D.90

1 x DTT: 2,3-DIHYDROXY-1,4-DITHIOBUTANE(Non-covalent)

DTT.2: 2 residues within 4Å: Chain B: W.43, Q.80 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Carbain, B. et al., 8-Substituted O6-Cyclohexylmethylguanine Cdk2 Inhibitors; Using Structure-Based Inhibitor Design to Optimise an Alternative Binding Mode. J.Med.Chem. (2014)

Release Date

2013-12-18

Peptides

CYCLIN-DEPENDENT KINASE 2: A
CYCLIN-A2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

CYCLIN-DEPENDENT KINASE 2

CYCLIN-A2

Related Entries With Identical Sequence